| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| CR201_G0036272 | ENSPPYP00000006905 | ENSPPYP00000004786 | ENSPPYP00000006905 | PTMS isoform 3. | Prothymosin alpha-like. | 0.793 |
| CR201_G0036272 | LOC100446293 | ENSPPYP00000004786 | ENSPPYP00000014685 | PTMS isoform 3. | PTMA isoform 5. | 0.793 |
| CR201_G0036272 | LOC100454770 | ENSPPYP00000004786 | ENSPPYP00000015330 | PTMS isoform 3. | Prothymosin alpha-like. | 0.749 |
| CR201_G0036272 | PTMA | ENSPPYP00000004786 | ENSPPYP00000004369 | PTMS isoform 3. | Prothymosin alpha, N-terminally processed; Prothymosin alpha may mediate immune function by conferring resistance to certain opportunistic infections; Belongs to the pro/parathymosin family. | 0.793 |
| CR201_G0036272 | SERINC1 | ENSPPYP00000004786 | ENSPPYP00000019007 | PTMS isoform 3. | Serine incorporator 1; Enhances the incorporation of serine into phosphatidylserine and sphingolipids. | 0.568 |
| CR201_G0036272 | SERINC3 | ENSPPYP00000004786 | ENSPPYP00000012323 | PTMS isoform 3. | Serine incorporator 3; Restriction factor required to restrict infectivity of gammaretroviruses: acts by inhibiting early step of viral infection and impairing the ability of the viral particle to translocate its content to the cytoplasm. | 0.517 |
| CR201_G0036272 | SERINC5 | ENSPPYP00000004786 | ENSPPYP00000017432 | PTMS isoform 3. | SERINC5 isoform 1. | 0.473 |
| CR201_G0036272 | TSG101 | ENSPPYP00000004786 | ENSPPYP00000003942 | PTMS isoform 3. | TSG101 isoform 4. | 0.467 |
| ENSPPYP00000006905 | CR201_G0036272 | ENSPPYP00000006905 | ENSPPYP00000004786 | Prothymosin alpha-like. | PTMS isoform 3. | 0.793 |
| LOC100446293 | CR201_G0036272 | ENSPPYP00000014685 | ENSPPYP00000004786 | PTMA isoform 5. | PTMS isoform 3. | 0.793 |
| LOC100454770 | CR201_G0036272 | ENSPPYP00000015330 | ENSPPYP00000004786 | Prothymosin alpha-like. | PTMS isoform 3. | 0.749 |
| PTMA | CR201_G0036272 | ENSPPYP00000004369 | ENSPPYP00000004786 | Prothymosin alpha, N-terminally processed; Prothymosin alpha may mediate immune function by conferring resistance to certain opportunistic infections; Belongs to the pro/parathymosin family. | PTMS isoform 3. | 0.793 |
| SERINC1 | CR201_G0036272 | ENSPPYP00000019007 | ENSPPYP00000004786 | Serine incorporator 1; Enhances the incorporation of serine into phosphatidylserine and sphingolipids. | PTMS isoform 3. | 0.568 |
| SERINC3 | CR201_G0036272 | ENSPPYP00000012323 | ENSPPYP00000004786 | Serine incorporator 3; Restriction factor required to restrict infectivity of gammaretroviruses: acts by inhibiting early step of viral infection and impairing the ability of the viral particle to translocate its content to the cytoplasm. | PTMS isoform 3. | 0.517 |
| SERINC3 | SERINC5 | ENSPPYP00000012323 | ENSPPYP00000017432 | Serine incorporator 3; Restriction factor required to restrict infectivity of gammaretroviruses: acts by inhibiting early step of viral infection and impairing the ability of the viral particle to translocate its content to the cytoplasm. | SERINC5 isoform 1. | 0.911 |
| SERINC5 | CR201_G0036272 | ENSPPYP00000017432 | ENSPPYP00000004786 | SERINC5 isoform 1. | PTMS isoform 3. | 0.473 |
| SERINC5 | SERINC3 | ENSPPYP00000017432 | ENSPPYP00000012323 | SERINC5 isoform 1. | Serine incorporator 3; Restriction factor required to restrict infectivity of gammaretroviruses: acts by inhibiting early step of viral infection and impairing the ability of the viral particle to translocate its content to the cytoplasm. | 0.911 |
| TSG101 | CR201_G0036272 | ENSPPYP00000003942 | ENSPPYP00000004786 | TSG101 isoform 4. | PTMS isoform 3. | 0.467 |
